share_log

Moderna and Generation Bio Announce Collaboration To Develop Non-Viral Genetic Medicines;Generation Bio To Receive $40M Upfront Cash Payment, Prepayment Of Research Funding Plus $36M Equity Investment From Moderna

Moderna and Generation Bio Announce Collaboration To Develop Non-Viral Genetic Medicines;Generation Bio To Receive $40M Upfront Cash Payment, Prepayment Of Research Funding Plus $36M Equity Investment From Moderna

Moderna 和 Generation Bio 宣布合作開發非病毒遺傳藥物；新代生物將獲得 40 萬美元的預付現金支付，預付研究資金以及來自 Moderna 的 36 億美元股權投資
Benzinga ·  2023/03/23 19:05

Moderna and Generation Bio Announce Collaboration To Develop Non-Viral Genetic Medicines;Generation Bio To Receive $40M Upfront Cash Payment, Prepayment Of Research Funding Plus $36M Equity Investment From Moderna

Moderna 和 Generation Bio 宣布合作開發非病毒遺傳藥物；新代生物將獲得 40 萬美元的預付現金支付，預付研究資金以及來自 Moderna 的 36 億美元股權投資

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論